Does ADALIMUMAB-AATY Cause Off label use? 56 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Off label use have been filed in association with ADALIMUMAB-AATY (Yuflyma). This represents 3.3% of all adverse event reports for ADALIMUMAB-AATY.
56
Reports of Off label use with ADALIMUMAB-AATY
3.3%
of all ADALIMUMAB-AATY reports
4
Deaths
17
Hospitalizations
How Dangerous Is Off label use From ADALIMUMAB-AATY?
Of the 56 reports, 4 (7.1%) resulted in death, 17 (30.4%) required hospitalization, and 4 (7.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-AATY. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB-AATY Cause?
Intentional dose omission (338)
Drug ineffective (151)
Intentional product use issue (151)
Death (132)
Arthralgia (96)
Rheumatoid arthritis (94)
Fatigue (92)
Therapy interrupted (88)
Crohn's disease (87)
Headache (86)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ADALIMUMAB-AATY Alternatives Have Lower Off label use Risk?
ADALIMUMAB-AATY vs ADALIMUMAB-ADAZ
ADALIMUMAB-AATY vs ADALIMUMAB-ADBM
ADALIMUMAB-AATY vs ADALIMUMAB-AFZB
ADALIMUMAB-AATY vs ADALIMUMAB-ATTO
ADALIMUMAB-AATY vs ADALIMUMAB-BWWD